OBSIDIAN THERAPEUTICS
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy to every patient with cancer.The company's next-generation cell and gene therapies with pharmacologic operating systems provide exquisite control of protein activity in cells and create adoptive cell therapies with new functions that are under control of the treating physician using simple, safe, orally-active, marketed drugs, enabling patients to improve on the current generation of cell therapies.
OBSIDIAN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.obsidiantx.com
Total Employee:
51+
Status:
Active
Contact:
(781) 806-6245
Email Addresses:
[email protected]
Total Funding:
164.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box Amazon
Similar Organizations
Ankyra
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
b.well Connected Health
b.well Connected Health provides an integrated solution for consumer engagement, holistic health management, and cost containment.
CareRx
CareRx is a provider of pharmacy services to seniors communities.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Cybin
Cybin is a life sciences company dedicated in advancing psychedelic therapeutics with the goal of transforming mental healthcare.
Denteric
Denteric is developing a vaccine based on research conducted at the University of Melbourne.
Dracen Pharmaceuticals
Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
EIP Pharma
EIP Pharma Provides Healthcare Services.
Everest Medicines
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Genomic Prediction
Genomic Prediction provides advanced genetic testing for IVF.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Jaguar Health
Jaguar Health brings naturally derived important health solutions to all animals of the world, as proprietary.
Kalderos
Kalderos provides a SaaS based drug discount management solution, which identifies, checks, and resolves non-compliance.
Neukio Biotherapeutics
Neukio Biotherapeutics is a developer of allogenic immune cell therapies for treatment of cancer.
Nivien Therapeutics
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Sante Basque Developpement
Sante Basque Developpement is owns and operates mental health hospitals.
Syndesi Therapeutics
Syndesi Therapeutics develops a drug candidate for the treatment of consecutive cognitive disorders of various neurological conditions.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Tune Therapeutics
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Westlake Therapeutics
The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.
Zucara Therapeutics
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series B - Obsidian Therapeutics
Vertex Ventures HC
Vertex Ventures HC investment in Series B - Obsidian Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Obsidian Therapeutics
Amgen Ventures
Amgen Ventures investment in Series B - Obsidian Therapeutics
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Obsidian Therapeutics
Logos Capital
Logos Capital investment in Series B - Obsidian Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Obsidian Therapeutics
Deep Track Capital
Deep Track Capital investment in Series B - Obsidian Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - Obsidian Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Obsidian Therapeutics
Official Site Inspections
http://www.obsidiantx.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.15 K
- Host name: 2.198.243.35.bc.googleusercontent.com
- IP address: 35.243.198.2
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Obsidian Therapeutics"
Pioneering engineered cell and gene therapies - Obsidian โฆ
Dr. Pao served as Chief Development Officer and Executive Vice President for Pfizer, where he was a member of the Executive Leadership Team and led the Global Product Development โฆSee details»
Obsidian Therapeutics - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number (781) 806-6245 Obsidian Therapeutics is a developer of a next-generation cell and gene therapies โฆSee details»
Obsidian Therapeutics Announces Appointment of William Pao, โฆ
CAMBRIDGE, Mass., June 4, 2024 โ Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of โฆSee details»
Obsidian Therapeutics Company Overview, Contact Details
Apr 3, 2024 Dec 11, 2023 | obsidiantx.com. Obsidian Therapeutics, Inc. launched OBX-115 on Jul 1st '22. In July 2022, CTMC and Obsidian Therapeutics announced FDA clearance of the โฆSee details»
Obsidian Therapeutics - LinkedIn
Obsidian Therapeutics Biotechnology Research Cambridge, MA 9,966 followers At Obsidian, our vision is pioneering engineered cell & gene therapies to deliver transformative outcomes for patients.See details»
Obsidian Therapeutics - VentureRadar
"Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies with pharmacologic operating systems. Based upon founding work on destabilizing โฆSee details»
MD Anderson and Obsidian Therapeutics announce FDA clearance โฆ
Information, please visit www.obsidiantx.com and follow us on LinkedIn and Twitter. About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of โฆSee details»
Obsidian Therapeutics, Inc. (Obsidian Therapeutics, Inc.) - ่ฏ็ฉ็ฎก โฆ
CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Obsidian Therapeutics, Inc. , a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced that โฆSee details»
News - Obsidian Therapeutics
Based upon the work of Professor Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian was founded in 2015 and is funded by a strong syndicate of venture investors. The company is headquartered in โฆSee details»
Obsidian Therapeutics - Overview, News & Similar companies
Obsidian Therapeutics contact info: Phone number: (781) 806-6245 Website: www.obsidiantx.com What does Obsidian Therapeutics do? Obsidian Therapeutics, Inc. is a โฆSee details»
Vertex and Obsidian Therapeutics Establish Collaboration to โฆ
Apr 22, 2021 For more information, please visit www.obsidiantx.com. About Vertex Pharmaceuticals. Vertex is a global biotechnology company that invests in scientific innovation โฆSee details»
MD Anderson and Obsidian Therapeutics announce FDA โฆ
Jul 21, 2022 For more information, please visit www.obsidiantx.com and follow us on LinkedIn and Twitter. Obsidian Therapeutics Media Contact: Erica Fiorini, Ph.D., or Liz Philips Russo โฆSee details»
Obsidian Therapeutics Announces Positive Interim Top-Line
Obsidian Therapeutics, Inc. is a clinicalstage- biotechnology company pioneering engineered cell and gene therapies to deliver transformative outcomes for patients with intractable diseases.See details»
Vertex and Obsidian Therapeutics Establish Collaboration to โฆ
Obsidianโs proprietary cytoDRiVE® technology provides a way to control protein degradation using FDA-approved small molecules, permitting precise control of the timing and level of โฆSee details»
Recommended Stories - Yahoo Finance
CAMBRIDGE, Mass., December 12, 2023--Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, announced today โฆSee details»
Obsidian Therapeutics to Present Clinical Data from OBX-115, its ...
CAMBRIDGE, Mass., April 24, 2024--Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced two presentations, โฆSee details»
Obsidian Therapeutics to Present at Upcoming Investor Conferences
Obsidian is headquartered in Cambridge, Mass. The Company has collaborations with Bristol Myers Squibb and Vertex Pharmaceuticals. For more information, please visit โฆSee details»
Working at Obsidian Therapeutics - Glassdoor
Obsidiantx.com. Obsidian Therapeutics Announces Closing of $115 Million Series B Financing. Like. 0. See all company updates. Work at Obsidian Therapeutics? Share your experiences. โฆSee details»
Obsidian Therapeutics to Present Preclinical Data Supporting OBX โฆ
Preclinical data confirm the successful generation of OBX-115 using core needle biopsy tumor tissue procurement in NSCLC Additional posters showcase the ability of cytoDRiVE regulation โฆSee details»